- 114.3k views
Understanding Gastric Cancer
Gastric cancer, often referred to as stomach cancer, is a malignancy that begins in the cells lining the stomach. Several factors increase the risk of developing gastric cancer, including infection with Helicobacter pylori bacteria, a family history of the disease, smoking, and a diet high in salty or smoked foods. Gastric cancer can be categorized into several types, with adenocarcinoma being the most common. Other rare types include lymphoma, stromal tumors, and carcinoid tumors. Early-stage gastric cancer often shows no symptoms. As the disease progresses, symptoms may include abdominal pain, indigestion, unintentional weight loss, and difficulty swallowing. Diagnosis typically involves endoscopy, where a flexible tube with a camera is inserted into the stomach to examine the lining and take biopsies. Imaging studies like CT scans and X-rays may also be used. Gastric cancer is staged to determine the extent of the disease. Stages range from 0 (limited to the inner lining) to IV (spread to distant organs). Treatment options depend on the stage and location of the cancer but may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapies, or immunotherapy.
About the Speaker
Dr. Raajit Chanana
Senior Consultant Medical Oncology, Dharamshila Narayana Superspeciality Hospital, New Delhi.
Upcoming Case Discussions
Preparing your Practice for Adoption of AI
Preparing Your Practice for Adoption of AI" involves building a foundation of digital literacy, data readiness, and ethical awareness among clinicians and staff. Successful integration starts with identifying key workflows where AI can enhance efficiency, accuracy, or patient outcomes. It’s essential to choose tools that align with your practice’s goals while ensuring transparency, security, and compliance. Training, change management, and continuous evaluation are critical to fostering trust and long-term adoption. Ultimately, AI should support—not replace—the human touch in medicine.
AI in Medicine: Challenges and Opportunities
AI in Medicine: Challenges and Opportunities explores the transformative potential of artificial intelligence in improving diagnostics, treatment planning, and healthcare delivery. The session highlights how AI can enhance clinical accuracy, streamline workflows, and support personalized medicine. At the same time, it addresses key challenges such as data privacy, algorithm bias, and the need for regulatory oversight. Real-world applications and case studies illustrate both the promise and the pitfalls of integrating AI into clinical practice. This session aims to equip healthcare professionals with a balanced view of how AI can complement human expertise in medicine.
Sleep Apnea and Daytime Fatigue
Sleep Disorder Breathing is a term for a group of conditions with abnormal breathing patterns during sleep. This affects everyday functioning and well being.There are few types of SDB which include upper airways resistance, hypopnea, apnea, catathrenia and heavy snoring. People suffering with SDB can have daytime symptoms that result in poor sleep also. There can also be sleepiness, depressed mood, irritability and cognitive dysfunction.
Common Surgical Emergencies in Newborn – Case scenarios
Neonatal surgery is an emergency service; it would not be appropriate to use extremely expensive equipment and highly specialized skills for a procedure that might wait. In fact, most neonatal surgery is performed with the intention of preserving lives. New surgical techniques for the treatment of other congenital anomalies are improbable, except from the inevitable rise in operations for congenital heart disease during the newborn period. The majority of specialized neonatal surgical units have found that children do not pass away from the condition for which they were referred; instead, they pass away from severe prematurity, respiratory difficulties, and accompanying abnormalities, many of which are incurable. Any improvement in outcomes is probably going to come from ventilation.
Ayurvedic Path to Parkinson’s Relief: Research Based Perspective
Ayurvedic Path to Parkinson's Relief: A Research-Based Perspective explores how ancient Ayurvedic principles can complement modern approaches in managing Parkinson's disease. Drawing from recent clinical studies and traditional wisdom, this session delves into the use of herbal formulations, Panchakarma therapies, and lifestyle modifications to alleviate motor and non-motor symptoms. It highlights the neuroprotective potential of key herbs like Mucuna pruriens and Ashwagandha. Backed by evidence and expert insights, the session aims to bridge traditional healing with modern neurological care for holistic patient outcomes.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Raajit Chanana's Talks on Assimilate
- 5th-October-2023, TIME : 05:00PM - 06:00PM
- 0
Gastric cancer, often referred to as stomach cancer, is a malignancy that begins in the cells lining the stomach. Several factors increase the risk of developing gastric cancer, including infection with Helicobacter pylori bacteria, a family history of the disease, smoking, and a diet high in salty or smoked foods. Gastric cancer can be categorized into several types, with adenocarcinoma being the most common. Other rare types include lymphoma, stromal tumors, and carcinoid tumors. Early-stage gastric cancer often shows no symptoms. As the disease progresses, symptoms may include abdominal pain, indigestion, unintentional weight loss, and difficulty swallowing. Diagnosis typically involves endoscopy, where a flexible tube with a camera is inserted into the stomach to examine the lining and take biopsies. Imaging studies like CT scans and X-rays may also be used. Gastric cancer is staged to determine the extent of the disease. Stages range from 0 (limited to the inner lining) to IV (spread to distant organs). Treatment options depend on the stage and location of the cancer but may include surgery to remove the tumor, chemotherapy, radiation therapy, targeted therapies, or immunotherapy.